Medoc

Company Overview

Snapshot

Founded in June 1990 by Udi Gafni, Medoc operates with 51–200 employees. The company specializes in neurodiagnostic medical systems for pain assessment and monitoring. Medoc holds a patent for rapid pain stimulation technology, which has facilitated advancements in functional MRI and pharmaceutical research.

Business overview

Medoc develops and manufactures neurodiagnostic medical systems designed for assessing and monitoring acute and chronic pain. Its core technology involves noninvasive, painless diagnosis and assessment capabilities for research and clinical environments, based on quantitative sensory testing techniques. The company's product lines, including Q-Sense fMRI System and TSA-II, are integrated into user-friendly, cost-effective systems. Medoc serves various disciplines within the healthcare and life sciences sectors, including clinics, laboratories, and pharmaceutical companies, with all products being FDA approved, CSA certified, and CE marked.

Company Intelligence Q&A

What is Medoc's primary focus?

Medoc develops and manufactures neurodiagnostic medical systems used to assess and monitor acute and chronic pain, utilizing technologies that test and evaluate peripheral sensory nerve fibers.

When was Medoc founded and by whom?

Medoc was founded in June 1990 by Udi Gafni, who serves as the Founder & CEO.

What certifications do Medoc's products hold?

All of Medoc's products are FDA approved, certified by CSA, and CE marked to the EN-60601-1 International Safety Standard.

What is the significance of Medoc's patented technology?

Medoc's patented rapid pain stimulation technology has enabled new developments in areas such as functional MRI, pharmaceutical research, and other pain-related treatments and testing modalities.

In which markets does Medoc operate?

Medoc's products are used in a wide range of global markets, including the United States, Japan, Germany, United Kingdom, Canada, Australia, China, and Israel, among others.